In separate letters, Intellia Therapeutics and Editas Medicine criticize a recent report in Nature Methods that found that CRISPR/Cas9-based gene editing led to unexpected changes, Technology Review
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Don't have a GenomeWeb or 360Dx account?Register for Free.
The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.
New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.
In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.
Holden Thorp is to be the new editor-in-chief of Science and its related journals.